Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Accounts Payables: 2009-2019

Historic Accounts Payables for Fresenius Medical Care AG (FMS) over the last 12 years, with Q3 2020 value amounting to $851.1 million.

  • Fresenius Medical Care AG's Accounts Payables rose 1683.93% to $851.1 million in Q3 2020 from the same period last year, while for Sep 2020 it was $851.1 million, marking a year-over-year increase of 1683.93%. This contributed to the annual value of $802.5 million for FY2019, which is 592.76% up from last year.
  • Per Fresenius Medical Care AG's latest filing, its Accounts Payables stood at $851.1 million for Q3 2020, which was up 1683.93% from $746.9 million recorded in Q2 2020.
  • Fresenius Medical Care AG's Accounts Payables' 5-year high stood at $851.1 million during Q3 2020, with a 5-year trough of -$594.3 million in Q2 2016.
  • Moreover, its 5-year median value for Accounts Payables was $695.3 million (2017), whereas its average is $471.0 million.
  • Per our database at Business Quant, Fresenius Medical Care AG's Accounts Payables crashed by 21075.37% in 2016 and then surged by 12862530.47% in 2019.
  • Fresenius Medical Care AG's Accounts Payables (Quarter) stood at $621.4 million in 2016, then increased by 11.88% to $695.3 million in 2017, then rose by 5.28% to $731.9 million in 2018, then increased by 8.36% to $793.1 million in 2019, then rose by 7.31% to $851.1 million in 2020.
  • Its Accounts Payables was $851.1 million in Q3 2020, compared to $746.9 million in Q2 2020 and $841.6 million in Q1 2020.